Balchem Statistics
Total Valuation
Balchem has a market cap or net worth of $5.28 billion. The enterprise value is $5.29 billion.
| Market Cap | 5.28B |
| Enterprise Value | 5.29B |
Important Dates
The next estimated earnings date is Thursday, April 23, 2026, before market open.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | Dec 23, 2025 |
Share Statistics
Balchem has 32.03 million shares outstanding. The number of shares has decreased by -0.35% in one year.
| Current Share Class | 32.03M |
| Shares Outstanding | 32.03M |
| Shares Change (YoY) | -0.35% |
| Shares Change (QoQ) | -0.84% |
| Owned by Insiders (%) | 0.65% |
| Owned by Institutions (%) | 90.16% |
| Float | 31.81M |
Valuation Ratios
The trailing PE ratio is 34.53 and the forward PE ratio is 28.85. Balchem's PEG ratio is 3.17.
| PE Ratio | 34.53 |
| Forward PE | 28.85 |
| PS Ratio | 5.00 |
| Forward PS | 4.63 |
| PB Ratio | 4.13 |
| P/TBV Ratio | 18.68 |
| P/FCF Ratio | 29.98 |
| P/OCF Ratio | 23.96 |
| PEG Ratio | 3.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.79, with an EV/FCF ratio of 30.59.
| EV / Earnings | 34.19 |
| EV / Sales | 5.10 |
| EV / EBITDA | 20.79 |
| EV / EBIT | 25.29 |
| EV / FCF | 30.59 |
Financial Position
The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.07 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | 1.04 |
| Interest Coverage | 20.48 |
Financial Efficiency
Return on equity (ROE) is 12.86% and return on invested capital (ROIC) is 11.77%.
| Return on Equity (ROE) | 12.86% |
| Return on Assets (ROA) | 8.02% |
| Return on Invested Capital (ROIC) | 11.77% |
| Return on Capital Employed (ROCE) | 13.86% |
| Weighted Average Cost of Capital (WACC) | 9.24% |
| Revenue Per Employee | $767,131 |
| Profits Per Employee | $114,530 |
| Employee Count | 1,352 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 5.08 |
Taxes
In the past 12 months, Balchem has paid $44.19 million in taxes.
| Income Tax | 44.19M |
| Effective Tax Rate | 22.20% |
Stock Price Statistics
The stock price has decreased by -1.95% in the last 52 weeks. The beta is 0.94, so Balchem's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -1.95% |
| 50-Day Moving Average | 171.35 |
| 200-Day Moving Average | 159.76 |
| Relative Strength Index (RSI) | 31.66 |
| Average Volume (20 Days) | 195,074 |
Short Selling Information
The latest short interest is 337,598, so 1.05% of the outstanding shares have been sold short.
| Short Interest | 337,598 |
| Short Previous Month | 279,089 |
| Short % of Shares Out | 1.05% |
| Short % of Float | 1.06% |
| Short Ratio (days to cover) | 1.97 |
Income Statement
In the last 12 months, Balchem had revenue of $1.04 billion and earned $154.85 million in profits. Earnings per share was $4.75.
| Revenue | 1.04B |
| Gross Profit | 370.63M |
| Operating Income | 209.33M |
| Pretax Income | 199.03M |
| Net Income | 154.85M |
| EBITDA | 254.73M |
| EBIT | 209.33M |
| Earnings Per Share (EPS) | $4.75 |
Balance Sheet
The company has $74.57 million in cash and $180.69 million in debt, with a net cash position of -$106.12 million or -$3.31 per share.
| Cash & Cash Equivalents | 74.57M |
| Total Debt | 180.69M |
| Net Cash | -106.12M |
| Net Cash Per Share | -$3.31 |
| Equity (Book Value) | 1.26B |
| Book Value Per Share | 39.22 |
| Working Capital | 189.23M |
Cash Flow
In the last 12 months, operating cash flow was $216.56 million and capital expenditures -$43.49 million, giving a free cash flow of $173.07 million.
| Operating Cash Flow | 216.56M |
| Capital Expenditures | -43.49M |
| Depreciation & Amortization | 45.40M |
| Net Borrowing | -26.19M |
| Free Cash Flow | 173.07M |
| FCF Per Share | $5.40 |
Margins
Gross margin is 35.74%, with operating and profit margins of 20.18% and 14.93%.
| Gross Margin | 35.74% |
| Operating Margin | 20.18% |
| Pretax Margin | 19.19% |
| Profit Margin | 14.93% |
| EBITDA Margin | 24.56% |
| EBIT Margin | 20.18% |
| FCF Margin | 16.69% |
Dividends & Yields
This stock pays an annual dividend of $0.96, which amounts to a dividend yield of 0.59%.
| Dividend Per Share | $0.96 |
| Dividend Yield | 0.59% |
| Dividend Growth (YoY) | 10.34% |
| Years of Dividend Growth | 16 |
| Payout Ratio | 20.21% |
| Buyback Yield | 0.35% |
| Shareholder Yield | 0.94% |
| Earnings Yield | 2.98% |
| FCF Yield | 3.34% |
Analyst Forecast
The average price target for Balchem is $176.00, which is 6.80% higher than the current price. The consensus rating is "Buy".
| Price Target | $176.00 |
| Price Target Difference | 6.80% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on January 21, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Jan 21, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Balchem has an Altman Z-Score of 9.32 and a Piotroski F-Score of 8.
| Altman Z-Score | 9.32 |
| Piotroski F-Score | 8 |